Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    661
  • comments
    0
  • views
    2,153

About this blog

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies offering drug repurposing services. 

§  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.

§  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

  • Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  Small Molecule

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

Key companies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

 

Entries in this blog

The “Proteome Profiling Services Market, 2020-2030{RootsAnalysis}

https://www.rootsanalysis.com/reports/proteome-profiling-services.html   Key Inclusions §  A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purificatio

Narender

Narender in Roots Analysis

The market is fragmented, featuring the presence of both industry and non-industry{Roots}

With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.   To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/report

Narender

Narender in Roots Analysis

The proteome profiling services market is projected to grow at an annualized rate of ~15%<RootsAnalysis>

Roots Analysis has done a detailed study on “Proteome Profiling Services Market, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html   Key Market Insights §  Over 200 players situated across the globe, claim to offer a variety of services fo

Narender

Narender in Roots Analysis

The proteome profiling services market is projected to be worth USD 16 billion by 2030<Roots>

Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:   §  A detailed review of the overall landsc

Narender

Narender in Roots Analysis

The “Virtual Clinical Trial Service Providers Market, 2020-2050(RootsAnalysis)

https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market.html   Key Inclusions §  An overview of the current market landscape of companies offering solutions for virtual clinical trials, featuring information on year of establishment, geographical location, company size and types of services offered (study start-up, patient enrollment, drug logistics, data collection and analysis, and patient retention). §  Brief profiles of companies offering solu

Narender

Narender in Roots Analysis

Currently, many companies claim to have advanced technology platforms(Roots)

Owing to its patient-centric approach, virtual / decentralized clinical trials are believed to potentially transform the conventional clinical research process. Virtual clinical trials implement innovative and advanced technological solutions, such as telemedicine and remote monitoring to minimize delays associated with the overall drug development process. The increased adoption of digital solutions by the healthcare industry and the cost saving potential of virtual clinical trials are likely t

Narender

Narender in Roots Analysis

The virtual clinical trial service providers market is projected to grow: By RootsAnalysis:

Roots Analysis has done a detailed study on Virtual Clinical Trial Service Providers Market, 2020-2050, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 280+ page report, which features 180+ figures and 230+ tables, please visit this link   Key Market Insights §  Currently, many companies claim to have advanced technology platforms, which enable them to decentralize the clinical research process, the

Narender

Narender in Roots Analysis

The virtual clinical trial service providers market is estimated to be worth USD 12 billion in 2050:By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Virtual Clinical Trial Service Providers Market, 2020-2050”   The report features an extensive study of the current landscape of industry players that are offering various types of innovative clinical research platforms / solutions to the pharmaceutical and life sciences industries. Amongst other elements, the report features: §  An overview of the current market landscape of companies offering sol

Narender

Narender in Roots Analysis

The “Global Psychedelic Therapeutics Market, 2020-2030{RootsAnalysis}

https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html   Key Inclusions §  A detailed assessment of the current market landscape of psychedelic therapeutics, providing information on phase of development (commercial, clinical, preclinical, and discovery stage) of lead candidates, type of psychedelic substance, origin of psychedelic substance, target therapeutic area route of administration (intranasal, intravenous, oral, sublingual, topical and transderm

Narender

Narender in Roots Analysis

Nearly 70 players from across the world presently claim to be engaged in the development{Roots}

Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implic

Narender

Narender in Roots Analysis

Global Psychedelic therapeutics market is projected to grow at an annualized rate of ~15%(RootsAnalysis)

Roots Analysis has done a detailed study on Global Psychedelic Therapeutics Market, 2020-2030” covering key aspects of the industry and identifying potential future growth opportunities     To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this- https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html    Key Market Insights §  Nearly 70 players from across the world presently claim to be engaged in t

Narender

Narender in Roots Analysis

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030(Roots)

Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §  A detailed assessment

Narender

Narender in Roots Analysis

The “High Energy Chemistry / Hazardous Chemistry Services Market, 2020-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/high-energy-chemistry.html\   Key Inclusions §  A detailed review of the overall landscape of companies offering contract and custom services for HEC / hazardous chemistry-based API manufacturing, along with information on type of manufacturer (contract and custom manufacturer), year of establishment, company size, location of headquarters, number and location of manufacturing facilities, general service portfolio (type of product (APIs, inter

Narender

Narender in Roots Analysis

Presently, over 100 service providers across the globe have capabilities<Roots>

Various service providers claim to possess the required equipment for API synthesis under hazardous (high / low temperature and high / low pressure) conditions. Over time, the shift to high energy synthesis chemistries has demonstrated the benefits of closed, continuous reaction processes. Although many players continue to prefer the standard batch process, many are gradually adopting continuous flow technologies, especially for hazardous reactions.   To order this 240+ page report, wh

Narender

Narender in Roots Analysis

The High Energy Chemistry / Hazardous Chemistry- based API manufacturing services:By RootsAnalysis:

Roots Analysis has done a detailed study on High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 240+ page report, which features 90+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/high-energ

Narender

Narender in Roots Analysis

The High Energy / Hazardous Chemistry-based API manufacturing services market: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030.”   The report features an extensive study on the current landscape and the likely future potential of the companies offering services for API manufacturing based on high energy chemistry (HEC) / hazardous chemi

Narender

Narender in Roots Analysis

The “Gene Therapy Market (4th Edition), 2020-2030: RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html   Key Inclusions §  A detailed review of the overall market landscape of gene therapies and gene editing therapies, including information on phase of development (marketed, clinical, preclinical and discovery) of pipeline candidates, key therapeutic areas (autoimmune disorders, cardiovascular diseases, dermatological disorders, genetic disorders, hematological disorders, immunological disorders, inf

Narender

Narender in Roots Analysis

The gene therapy market is characterized by a healthy drug pipeline, with 10 approved{RootsAnalysis}

Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiatives.   To order this 720+ page report, which features 220+ figures

Narender

Narender in Roots Analysis

The gene therapy market is projected to grow at an annualized rate of 30%, till 2030{Roots}

Roots Analysis has done a detailed study on Gene Therapy Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 720+ page report, which features 220+ figures and 375+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html   Key Market Insights §  The gene therapy market is characterized by a healthy drug pipeline, with

Narender

Narender in Roots Analysis

The gene therapy market is estimated to be worth USD 14.6 billion in 2030(RootsAnalysis)

Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.   The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral therapies, immunotherapies and gene editing therapies. The study also features an elaborate discussion on the future potential of this evolving market. In addition to other elements, the study i

Narender

Narender in Roots Analysis

The gene therapy market is projected to be worth USD 14.6 billion in 2030(Roots)

Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings.   Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw

Narender

Narender in Roots Analysis

The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html   Key Inclusions §  A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of development, recruitment status, therapy design and type of cancer therapy.  §  An

Narender

Narender in Roots Analysis

Presently, close to 50 companies are offering a variety of analytical testing solutions<Roots>

Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.   To order this 370+ page report, which features 190+ figures and 180+ tables

Narender

Narender in Roots Analysis

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow: By RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html   Key Market Insights §  Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies are indicative of the growing interest in this domain §  Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel c

Narender

Narender in Roots Analysis

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”   The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an in-depth analysis, highlighting the capabilities of the various companies engaged in this domain. Amongs

Narender

Narender in Roots Analysis

×
  • Create New...